Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
AmorChem Invests in Novel Approach to Target Myc-driven Cancers
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft…
Approval
Allergan’s Durysta Implant Approved to Treat Glaucoma
Phase III
AstraZeneca Bladder Cancer Treatment Fails to Hit the Mark in Phase…
Approval
Novadoz Pharmaceuticals Increases Presence in the Generic Oncology Market with an…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
CEPI says funding gap of $2 billion could hamper COVID-19 vaccine…
Deals
AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA in Patients…
Commercial
Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent…
Deals
Announcement of Joint Research Agreement with Nagoya University for Spinal Cord…
Home
Clinical
Phase II
Phase II
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II
Dynacure Announces First Patient Dosed in Phase 1 / 2 ‘UNITE-CNM’ Study of DYN101 for the Treatment of Myotubular and Centronuclear Myopathies (CNM)
Biospace News
-
March 5, 2020
Phase II
Zynerba Pharmaceuticals Presents Data Showing that the Baseline Characteristics of Patients in Phase 2 BRIGHT Trial in Autism Spectrum Disorder Indicate a Moderate-to-Severe Study...
Phase II
Atossa Therapeutics, Inc. Files for Swedish Regulatory Approval to Initiate a Phase 2 Study of Oral Endoxifen to Reduce Mammographic Breast Density
Phase II
Ironwood Pharmaceuticals Announces Publication of Positive IW-3718 Phase IIb Data in Gastroenterology
Phase II
Menlo shares hit on failure of Phase II serlopitant trial in chronic pruritus of unknown origin
Phase II
Menlo shares hit on failure of Phase II serlopitant trial in...
Firstwordpharma News
-
February 26, 2020
0
Phase II
NGM Bio Announces Positive Preliminary Topline Liver Histology and Biomarker Data...
Biospace News
-
February 24, 2020
0
Phase II
DelMar Pharmaceuticals Enrolls Final Patient in Phase 2 Clinical Trial of...
Firstwordpharma News
-
February 19, 2020
0
Phase II
RIBOMIC Announces First Injection in the Phase 2 Clinical Trial of...
Firstwordpharma News
-
February 19, 2020
0
Phase II
CoImmune, Inc. Announces FDA Approval of its IND Application to Conduct...
Firstwordpharma News
-
February 19, 2020
0
1
2
3
...
30
Page 1 of 30
- Advertisement -
MOST POPULAR
Syndax Pharmaceuticals Reports Fourth Quarter 2018 Financial Results and Provides Clinical...
March 7, 2019
Lilly To Participate in SVB Leerink Global Healthcare Conference
February 21, 2020
FDA Action Alert: Sanofi, Motif Bio and Merck
February 4, 2019
SIIPL-PCV Vaccine Affordable, Effective, Safe for Immunising Children Against Pneumococcus: Presented...
May 13, 2019
Load more
HOT NEWS
Commercial
MacroGenics Announces Date of Third Quarter 2019 Financial Results Conference Call
Commercial
Provectus Biopharmaceuticals Announces Acceptances of PV-10 Poster Presentations at American Society...
Orphan-paediatric
Possible new treatment strategy against progeria
Deals
Datavant and Parexel Partner to Harness Real-World Evidence
